Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 3Multiple Myeloma 3Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1

Interventions

fludarabine phosphate 23Peripheral Blood Stem Cell Transplantation 21Whole-Body Irradiation 17Mycophenolic Acid 16Cyclophosphamide 15Cyclosporine 14Tacrolimus 11Antilymphocyte Serum 10Busulfan 9Methotrexate 7Melphalan 7Therapeutics 4Sirolimus 4Methylprednisolone 4Etoposide 4Transplantation 3Filgrastim 3Epoetin Alfa 3Darbepoetin alfa 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2sargramostim 2merphos 2liposomal amphotericin B 2Rituximab 2Radiotherapy 2Polymerase Chain Reaction 2Pharmacogenomic Testing 2Pentetic Acid 2Panobinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoblastic Lymphadenopathy × Heptavalent Pneumococcal Conjugate Vaccine × Plasma cell × Clear all
NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡